SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-17-011156
Filing Date
2017-10-02
Accepted
2017-10-02 17:12:40
Documents
10

Document Format Files

Seq Description Document Type Size
1 forms3.htm S-3 591437
2 ex4-3.htm EX-4.3 399272
3 ex4-5.htm EX-4.5 155255
4 ex4-6.htm EX-4.6 156090
5 ex4-7.htm EX-4.7 146848
6 ex5-1.htm EX-5.1 70881
7 ex12-1.htm EX-12.1 89422
8 ex23-1.htm EX-23.1 4579
9 as_001.jpg GRAPHIC 6007
10 image_001.jpg GRAPHIC 13996
  Complete submission text file 0001493152-17-011156.txt   1642555
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-220769 | Film No.: 171115289
SIC: 2835 In Vitro & In Vivo Diagnostic Substances